60¢sixtycents

Bristol-Myers Squibb CompanyBMY

Is BMY cheap right now? Every multiple below is scored against its own 10-year range, not a sector average.

$64.69-2.13 (-3.19%)24:00 UTC
NYSEHealthcare

Company snapshot

Market Cap
$132B
Large-cap
+47%
2016 — today
10-Year Price
+20%
2016 — today
52-Week Range
$42.60$68.09
Current $64.69· 87%

Bristol-Myers Squibb researches, develops, and commercializes a global biopharmaceutical portfolio spanning hematology, oncology, cardiovascular health, immunology, fibrotic conditions, neuroscience, and infectious diseases. Key therapies include Revlimid, Eliquis, Opdivo, Pomalyst/Imnovid, Orencia, Sprycel, Yervoy, Abraxane, Reblozyl, Empliciti, Zeposia, Breyanzi, Inrebic, and Onureg. Products are distributed worldwide via wholesalers, pharmacies, hospitals, and clinics. Established in 1887, it is based in New York.

Similar companies

Healthcare companies of comparable size to BMY
CompanyP/EDiv yield
VRTXVertex Pharmaceuticals Incorporated30.8—
ISRGIntuitive Surgical, Inc.39.8—
CVSCVS Health Corporation25.42.8%
DHRDanaher Corporation36.50.7%
MDTMedtronic plc22.83.1%
PFEPfizer Inc.36.76.2%
SYKStryker Corporation28.61.3%
MCKMcKesson Corporation23.80.4%

Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.

Valuation in context

P/E ratio
14.2
Below average
Below the 10-year average
Sector median 25.2below sector
P/B ratio
5.9
Above average
Pricier than usual over the last 10 years
Sector median 2.6above sector
EV / EBITDA
10.0
Below average
Below the 10-year average
Sector median 15.6below sector
Dividend Yield
3.9%
Above average
Above the 10-year average
Sector median 1.7%above sector
FCF Yield
8.6%
Around average
Around the 10-year average
Sector median -9.4%above sector
Free · No credit card needed

Get alerted when BMY is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.